---
schema_version: "secwatch.filing_event.v1"
accession: "0001645113-24-000016"
form_type: "8-K"
ticker: "NVCR"
cik: "0001645113"
company_name: "NovoCure Ltd"
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:18:39.579087+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Shareholders elect 10 directors, approve 2024 Omnibus Incentive Plan at AGM

## Summary
- Approximately 85.9M shares (79.8% of eligible) voted at June 5 AGM; all 10 director nominees elected.
- Auditor ratification passed: 80.1M for, 5.7M against, 0.09M abstain.
- Non-binding advisory vote on executive compensation approved: 69.6M for, 1.2M against.
- 2024 Omnibus Incentive Plan approved: 60.1M for (73.7% of votes cast), 10.8M against.
- Say-on-pay frequency set at one year: 70.5M for one year vs 0.4M for three years.

## SEC filing metadata
- accession: 0001645113-24-000016
- form_type: 8-K
- ticker: NVCR
- cik: 0001645113
- company_name: NovoCure Ltd
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645113/000164511324000016/0001645113-24-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645113/000164511324000016/nvcr-20240605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001645113-24-000016
- JSON: https://secwatch.observer/filing/0001645113-24-000016.json
- Plain text: https://secwatch.observer/filing/0001645113-24-000016.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.